Since PPAR-α, PPAR-γ, and LXR agonists have antidiabetic efficacy in animal model of diabetes (Srivastava, 2009), we first ascertained that these agonists show antidiabetic efficacy in ob/ob mice. Here, PPARA is linked to diabetes mellitus.